✦ LIBER ✦

Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?

✍ Scribed by Roger G. Owen; Im Fan; Sheila J. M. O'Connor; Rebecca A. Rollett; J. Anthony Child; Faith E. Davies; Andy C. Rawstron

Book ID: 108674036
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 207 KB
Volume: 136
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2006.06376.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclooxygenase-2 in multiple myeloma: pr

Cyclooxygenase-2 in multiple myeloma: prognostic factor or therapeutic target? – Response to Owen et al

✍ R. E. Kast 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

TGFβR2 aberrant methylation is a potenti

TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma

✍ Fabrício de Carvalho; Gisele W. B. Colleoni; Manuella S. Sampaio Almeida; André 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

## Abstract Multiple myeloma (MM) is an incurable hematological malignancy. Different studies demonstrated the occurrence of genetic and epigenetic alterations in MM. The aberrant methylation is one of the most frequent epigenetic alterations in human genome. This study evaluated the aberrant methy

Prognostic factors in multiple myeloma:

Prognostic factors in multiple myeloma: role of ?2-microglobulin and thymidine kinase

✍ Diem, H. ;Fateh-Moghadam, A. ;Lamerz, R. 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 722 KB

Serum [32-microglobulin , serum thymidine kinase, and commonly used prognostic parameters were investigated for their prognostic value in a well-defined group of patients with multiple myeloma (n = 207). Multivariate analysis showed hemoglobin to be the parameter of strongest prognostic value. Only

Single-institute phase 2 study of thalid

Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile

✍ Yutaka Hattori; Shin-ichiro Okamoto; Naoki Shimada; Tsunayuki Kakimoto; Kunihiko 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Technetium-99m 2-methoxy-isobutyl-isonit

Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors

✍ N. Erten; B. Saka; K. Berberoglu; C. Turkmen; S. Unal; B. Bakir; E. Yekeler; S. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 308 KB

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple